The Maternity Monopoly is Over: Why Payers are Pivoting to Menopause

Health plans are officially pivoting: 33% rank Menopause as their top investment priority, outpacing Maternity three-to-one.

Boston MA -- October 12: For decades, commercial investment in women’s health was almost exclusively synonymous with maternal and fertility care. That era is officially over.

The Women's Health Infrastructure Report 2026 reveals a massive reallocation of capital toward the "missing middle" of women's healthcare: midlife and chronic disease.

Survey responses indicate a rapid shift toward a lifespan perspective[cite: 10]. Driven by rising awareness of the long-term economic impact of untreated midlife conditions, payers are aggressively prioritizing Menopause (33%) and Chronic Disease Management (28%) over traditional Maternal Health (11%) interventions.

"As we recognize the status of being postmenopausal will last 30 or more years, and along with this is an association with an increase in chronic conditions that impact healthy aging, how do we confidently direct women to optimize their health for the next 3-4 decades? Women want to age well; we should be able to advise them with evidence-based data."

Barb DePree

Director of Women's Health, Holland Hospital

This finding represents just one of dozens of insights uncovered through the Women's Health Infrastructure Report 2026, a cross-sector study bringing together perspectives from health plans, providers, employers, clinicians, life sciences organisations and innovators.

The full report features detailed findings, expert commentary, benchmark data and practical implications for healthcare leaders looking to understand where women's health is heading next.

Lead Research Partner